About Intrexon Corporation
Intrexon Corporation is a company based in Germantown (United States) founded in 1998. Intrexon Corporation has raised $250 million across 3 funding rounds.
- Headquarter Germantown, United States
- SectorsHealthcare
- Website dna.com
- Total Equity Funding$250M (USD)
in 3 rounds
- Latest Funding Round$25M (USD), Post-IPO
Mar 2014
Funding Insights of Intrexon Corporation
Intrexon Corporation has successfully raised a total of $250M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250M
- Total Rounds 3
- Last Round Post-IPO — $25M
- First Round $100M
(May 2011)
All 3 funding rounds of Intrexon Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2014 | $25M | Post-IPO | – | – | – |
| May 2013 | $150M | Series G | – | – | – |
| May 2011 | $100M | Series E | – | – | – |
People of Intrexon Corporation
8 people are tracked at Intrexon Corporation (4 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Floyd Ross | Managing Director | Leadership |
Robert J Mills | Vice President, Cmc, Human Therapeutics Division | Leadership |
Kalvin Yim | Senior Director,cmc/process Development | Leadership |
Eric Miracle | Associate Director IT OPS | Leadership |
Lauren Esser | Senior Associate Scientist | Team |
Bob Yang | Principal Infrastructure Engineer | Team |
Homeyra Baghestani | Financial Processing Manager | Team |
Cynthia Gross | Pr. Scientist | Team |
Complete people profiles for Intrexon Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Intrexon Corporation
3 dated milestones of Intrexon Corporation across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Intrexon Corporation is founded.
- Funding First funding round of $100.0M.
- Funding Latest funding round, Post-IPO, of $25.0M.
Web traffic of Intrexon Corporation
Websites that share an audience with Intrexon Corporation (dna.com).
Websites whose visitors overlap most with Intrexon Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| beckmancoulter.com | 100% | 113.9K | #341,469 | View details | |
isispharm.com | isispharm.com | 100% | – | – | – |
| celera.com | 100% | – | – | View details | |
| bruker.com | 66% | 346K | #136,650 | View details | |
| ziopharm.com | 37% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Intrexon Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Intrexon Corporation
Complete news archive for Intrexon Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Intrexon Corporation
10 companies that operate in the same segment as Intrexon Corporation (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Intrexon Corporation
Intrexon Corporation was founded in 1998 and raised its 1st funding round 13 years after it was founded.
Intrexon Corporation is headquartered in Germantown, United States.
Intrexon Corporation is a funded company, having raised a total of $250M across 3 funding rounds to date. The company's 1st funding round was a Series E of $100M, raised on May 2011.
Intrexon Corporation was founded in 1998 and is headquartered in Germantown, United States. Operations focus on the biotechnology sector, where engineered multi-function genes and specialized gene activation compounds are utilized to develop therapeutics. These target advanced cancers, progressive neural disorders, and cardiac failure, addressing unmet needs in human disease treatment through genetic engineering approaches.